识别风险，发现价值 请务必阅读末页的免责声明 1/28 T ab l e _ P ag e 跟踪分析|医药生物 证券研究报告 Table_Title Table_Summary 1.56%2024 4 19 1.56%300 1.35 32 12 PE TTM 25x 300 217.1%298.4%1.67%300 1.88 3.24 3.43%0.81 1.89%2.20%2.47%30 IND 27 3 1.1 NDA B i ot ec h/-U-B A/H A/H-B 璟-U A/H 1 2 IVD A/H Table_Gr ade 2024-04-21 T ab l e _ P i cQ u o t e Table_Author SAC S0260516090004 SFC CE No.BOR756 021-38003671 SAC S0260520100005 021-38003669 Table_DocReport:2024-04-14:2024-04-07:2024-04-03 Table_Contacts-30%-23%-16%-10%-3%4%04/23 07/23 09/23 11/23 02/24 04/24 300708153 识别风险，发现价值 请务必阅读末页的免责声明 2/28 T ab l e _ P ag eT e x t 跟踪分 析|医药 生物 Table_impcom EPS()PE(x)EV/EBITDA(x)ROE(%)/2024E 2025E 2024E 2025E 2024E 2025E 2024E 2025E 600276.SH CNY 41.68 2023/10/26 53.11 0.89 1.06 46.83 39.32 40.21 34.14 12.10 12.80 600079.SH CNY 19.61 2024/04/06 38.57 1.54 1.85 12.73 10.60 7.00 5.90 12.50 12.80 002262.SZ CNY 23.28 2024/04/06 34.01 1.21 1.44 19.24 16.17 16.46 13.69 15.80 15.50 03692.HK HKD 15.38 2024/03/28 22.85 0.68 0.59 22.62 26.07 19.65 22.99 13.60 10.50 002422.SZ CNY 29.29 2023/11/02 47.39 1.90 2.14 15.42 13.69 9.99 9.22 12.60 12.10-U 688506.SH CNY 119.17 2024/03/03 164.56 10.01 0.17 11.91 701.00 10.27 300.55 95.80 1.60-B 02162.HK HKD 27.45 2023/08/27 80.29-1.51-0.48-18.18-57.19-62.97 41.68-10.20-3.30-U 688235.SH CNY 116.30 2023/11/13 179.37-1.67-0.29-530.13-10.20-1.80 06160.HK HKD 77.00 2023/04/28 173.85-1.34-0.27-4.50-0.80 002675.SZ CNY 12.36 2023/08/27 17.31 0.59 0.69 20.95 17.91 11.22 9.84 8.80 9.40-U 688180.SH CNY 24.62 2024/04/06 52.09-1.50-0.84-26.20-17.00 01093.HK HKD 5.77 2024/03/22 10.18 0.55 0.61 10.49 9.46 7.60 7.02 16.90 16.40 300573.SZ CNY 212.50 2023/10/27 177.58 5.92 8.24 35.90 25.79 28.62 21.21 27.70 27.80 002294.SZ CNY 28.13 2024/03/27 36.74 0.57 0.63 49.35 44.65 31.45 26.53 7.20 7.40-B 06855.HK HKD 15.70 2023/08/27 42.20-2.83-2.58-22.90-17.90 300723.SZ CNY 21.01 2023/10/27 43.33 1.08 1.34 19.45 15.68 13.09 10.90 17.20 17.50 02096.HK HKD 5.15 2024/03/25 11.79 0.42 0.52 12.26 9.90 9.24 7.84 13.30 13.90 002317.SZ CNY 14.33 2023/11/01 21.53 0.54 0.65 26.54 22.05 20.08 16.98 9.90 10.70 01801.HK HKD 33.20 2024/03/21 58.45-0.38 0.22-150.91-73.90 3.00 00013.HK HKD 26.00 2024/03/26 40.44-0.13 0.00-18.00 0.10 300122.SZ CNY 40.49 2023/12/01 92.68 4.63 5.41 8.75 7.48 7.23 6.22 26.00 23.90 300601.SZ CNY 19.94 2023/11/01 37.27 1.24 1.55 16.08 12.86 13.80 11.36 11.00 11.50 000661.SZ CNY 117.88 2024/03/20 188.52 12.57 14.28 9.38 8.25 6.53 5.75 20.10 19.80 300009.SZ CNY 9.77 2024/04/03 12.55 0.63 0.78 15.51 12.53 11.84 9.73 24.00 25.20 300294.SZ CNY 31.64 2024/04/02 36.46 1.14 1.26 27.75 25.11 20.22 18.42 7.30 7.60 300015.SZ CNY 12.14 2023/12/01 22.51 0.49 0.65 24.78 18.68 14.46 11.53 20.10 21.50 06078.HK HKD 28.30 2024/03/29 38.81 1.43 1.81 18.23 14.41 12.60 10.47 12.70 13.80 603882.SH CNY 44.41 2023/10/30 75.41 2.42 2.90 18.35 15.31 9.60 8.39 11.90 12.80 301267.SZ CNY 24.58 2023/10/25 53.02 1.07 1.39 22.97 17.68 13.51 10.91 13.10 14.60 301239.SZ CNY 50.32 2023/10/31 147.83 2.37 3.29 21.23 15.29 8.75 7.05 13.10 15.40 688315.SH CNY 12.81 2024/04/15 17.48 0.50 0.59 25.62 21.71 13.60 11.67 7.90 8.70 02273.HK HKD 42.00 2024/03/29 54.62 1.67 2.19 22.75 17.36 18.95 14.60 15.80 18.00 600763.SH CNY 53.10 2023/10/25 103.31 2.27 2.74 23.39 19.38 13.35 11.20 15.60 15.90 01951.HK HKD 2.27 2024/04/01 4.31 0.20 0.23 10.35 8.84 6.69 5.71 5.30 6.00 300896.SZ CNY 279.50 2024/03/25 396.00 11.31 15.03 24.71 18.60 29.85 22.51 29.50 30.30 000963.SZ CNY 31.50 2023/10/24 58.60 1.94 2.28 16.24 13.82 10.34 8.85 13.70 13.90 688050.SH CNY 134.60 2023/10/26 224.00 4.35 5.75 30.94 23.41 25.53 19.87 17.60 18.90 Wind 2023 A-U 2023 YWAZuNnQoNoPtNpMmRsNnM7NbP8OoMmMnPtPjMpPsOeRtRmOaQrQrQMYrNqQwMtPmR 识别风险，发现价值 请务必阅读末页的免责声明 3/28 T ab l e _ P ag eT e x t 跟踪分 析|医药 生物.6 BIOTECH.12.12.14.18.18.18.19.19.20.21.21.21.23.23.23.24.24.24.25.25.26.26.26 识别风险，发现价值 请务必阅读末页的免责声明 4/28 T ab l e _ P ag eT e x t 跟踪分 析|医药 生物 1%.6 2 H%.6 3.6 4 32.7 5 300 PE TTM.7 6.8 7 A pharma.12 8 A pharma.12 9 H pharma.12 10 H pharma.12 11 A biotech.13 12 A biotech.13 13 H biotech.13 14 H biotech.13 15.14 16.14 17.18 18.18 19 A.19 20 A.19 21 H.19 22 H.19 23.21 24.21 25.23 26.23 27.24 28.24 29.25 30.25 31.26 32.26 1 2023 2024.8 2 NDA IND.14 2MWYAPQYUlFpVnc8DAdDM8iCYydMK33bsDsO0TSEcfak5n623WBkLcsMZXLCt2Hg 识别风险，发现价值 请务必阅读末页的免责声明 5/28 T ab l e _ P ag eT e x t 跟踪分 析|医药 生物 3.16 4.18 5.20 6.21 7.23 8.24 识别风险，发现价值 请务必阅读末页的免责声明 6/28 T ab l e _ P ag eT e x t 跟踪分 析|医药 生物 Wind 2024 2024/04/19 Wind A 4.88%300 3.22%15.70%Wind A 10.82 300 18.92 2024 2024/04/19 4.83%28.86%24.03 1%2 H%Wind Wind 1.56%300 4.78 18.92 31.53%3 Wind-2500%-2000%-1500%-1000%-500%0%500%1000%2024-01-01 2024-02-01 2024-03-01 2024-04-01()A 300-3500%-3000%-2500%-2000%-1500%-1000%-500%0%500%2024-01-01 2024-02-01 2024-03-01 2024-04-01 3.22%-1.56%-1.88%-14.19%-15.41%-15.70%-20.20%-31.53%-35%-30%-25%-20%-15%-10%-5%0%5%300 II 识别风险，发现价值 请务必阅读末页的免责声明 7/28 T ab l e _ P ag eT e x t 跟踪分 析|医药 生物 1.56%300 0.21%300 1.35 32 12 4 32 Wind 2024 4 19 PE TTM 25x 300 217.1%2010 PE 72.7x 20.9x 300 298.4%5 300 PE TTM Wind-5%-4%-3%-2%-1%0%1%2%3%4%300 0%100%200%300%400%500%600%300 300 识别风险，发现价值 请务必阅读末页的免责声明 8/28 T ab l e _ P ag eT e x t 跟踪分 析|医药 生物 II 1.67%300 1.88 3.24 3.43%6 Wind 71 2023 46 2024 1 2023 2024 YOY YOY 2023 1 002390.SZ 2024/4/16 64.61 1.75%2.68 19.37%2 002788.SZ 2024/4/16 198.46 1.97%3.46 1.63%3 300341.SZ 2024/4/16 13.65-23.89%1.62-36.47%4 300401.SZ 2024/4/16 10.95-22.78%1.48-57.65%5 300685.SZ 2024/4/16 10.44 23.91%2.39 52.21%6 301234.SZ 2024/4/16 5.34-2.46%0.55-9.79%7 600535.SH 2024/4/16 86.74 0.94%11.81 63.64%8 605507.SH 2024/4/16 53.49-6.49%5.92-34.69%9 688253.SH 2024/4/16 4.78 7.03%1.47 10.99%10 688488.SH 2024/4/16 4.11 68.44%-0.88-42.59%11 688670.SH 2024/4/16 1.35-57.74%-0.73-420.85%12 837344.BJ 2024/4/16 2.45 43.12%0.29 40.42%13 000623.SZ 2024/4/17 34.49 20.25%13.13-14.18%14 600568.SH ST 2024/4/17 6.39 26.21%-3.72-52.18%15 688217.SH 2024/4/17 2.58-39.14%0.04-89.00%16 000963.SZ 2024/4/18 406.24 7.71%27.37 13.55%17 002219.SZ 2024/4/18 35.90 13.88%0.29-67.69%18 301075.SZ 2024/4/18 3.34-16.64%0.05-34.96%1.67%0.81%-0.21%-1.56%-1.89%-2.20%-2.47%-3.43%-4.0%-3.0%-2.0%-1.0%0.0%1.0%2.0%II 300 研报 识别风险，发现价值 请务必阅读末页的免责声明 9/28 T ab l e _ P ag eT e x t 跟踪分 析|医药 生物 19 301363.SZ 2024/4/18 13.38-5.49%2.91-25.95%20 600276.SH 2024/4/18 228.20 7.26%41.41 21.46%21 688050.SH 2024/4/18 9.51 64.14%2.89 38.96%22 688176.SH-U 2024/4/18 0.14 52604.25%-4.32 39.39%23 688626.SH 2024/4/18 7.45 52.46%2.04 162.31%24 833230.BJ 2024/4/18 2.43-9.88%0.14-56.33%25 835670.BJ 2024/4/18 0.97 35.21%0.08-235.43%26 000766.SZ 2024/4/19 14.73 0.18%0.29 45.35%27 000931.SZ 2024/4/19 22.77 10.50%0.36-170.84%28 002102.SZ 2024/4/19 111.29-9.23%-0.04-112.66%29 002287.SZ 2024/4/19 20.45 0.02%3.70-15.92%30 002349.SZ 2024/4/19 15.12-3.90%2.37 34.99%31 002365.SZ 2024/4/19 9.73-33.48%-0.76-162.11%32 002566.SZ 2024/4/19 8.54 2.85%0.76 15.54%33 300181.SZ 2024/4/19 19.42 7.61%3.74 41.14%34 300357.SZ 2024/4/19 8.48-5.34%2.98-5.20%35 300396.SZ 2024/4/19 13.78 12.95%2.62 5.40%36 300439.SZ 2024/4/19 18.86-24.23%1.96 14.89%37 300573.SZ 2024/4/19 14.68 17.42%2.40 15.59%38 301033.SZ 2024/4/19 2.31 18.24%0.37 55.54%39 301122.SZ 2024/4/19 4.10-11.82%0.85-38.98%40 301293.SZ 2024/4/19 13.13 22.93%0.94 79.74%41 600594.SH 2024/4/19 28.21 3.12%0.67-114.42%42 603309.SH 2024/4/19 13.88 1.79%1.80 23.25%43 603658.SH 2024/4/19 44.44 0.05%11.85 5.86%44 688358.SH 2024/4/19 4.84 27.04%1.37 39.39%45 830946.BJ 2024/4/19 5.90-5.46%1.28-14.55%46 000411.SZ 2024/4/20 320.52 4.68%4.05 102.35%47 002019.SZ 2024/4/20 40.68 6.03%-5.33-771.06%48 002437.SZ 2024/4/20 26.26-15.51%0.53-117.53%49 002653.SZ 2024/4/20 33.55 11.27%2.42 153.39%50 002898.SZ 2024/4/20 3.11 17.58%-0.02-95.53%51 002940.SZ 2024/4/20 16.26 3.66%1.07-11.19%52 300003.SZ 2024/4/20 79.80-24.78%11.23-47.58%53 300244.SZ 2024/4/20 134.08-33.89%2.95-81.90%54 300436.SZ 2024/4/20 4.23 9.58%-3.54 167.99%55 300558.SZ 2024/4/20 24.56 3.35%2.63 768.85%56 301520.SZ 2024/4/20 3.42 31.07%0.98 13.56%57 600436.SH 2024/4/20 100.58 15.69%28.54 15.26%58 600572.SH 2024/4/20 67.33 12.20%5.54 14.60%59 600851.SH 2024/4/20 11.83-17.88%1.59 2.13%研报 识别风险，发现价值 请务必阅读末页的免责声明 10/28 T ab l e _ P ag eT e x t 跟踪分 析|医药 生物 60 603079.SH 2024/4/20 7.27-1.44%-0.62-682.00%61 603168.SH 2024/4/20 6.45 17.37%-0.04-119.89%62 603669.SH 2024/4/20 1.97-31.95%-1.82-10.85%63 603987.SH 2024/4/20 24.53-21.36%2.23-23.49%64 603998.SH 2024/4/20 16.29-9.12%1.34 25.35%65 688026.SH 2024/4/20 4.63-24.06%0.32-57.90%66 688266.SH 璟-U 2024/4/20 3.86 27.83%-3.49-29.52%67 688301.SH 2024/4/20 18.64 20.31%5.91 14.43%68 688575.SH 2024/4/20 20.53-48.42%2.20-77.00%69 688607.SH 2024/4/20 2.74 33.81%0.01-104.57%70 688799.SH 2024/4/20 14.33 10.84%1.94 20.85%71 900917.SH B 2024/4/20 11.83-17.88%1.59 2.13%2024 1 002788.SZ 2024/4/16 51.36 6.08%0.83 5.21%2 300401.SZ 2024/4/16 3.30 4.15%0.61 41.29%3 301234.SZ 2024/4/16 0.90-23.28%0.08-27.50%4 605507.SH 2024/4/16 13.39-5.07%1.93 0.48%5 688253.SH 2024/4/16 2.82 109.36%1.37 198.41%6 688670.SH 2024/4/16 0.05-95.28%-0.24-174.70%7 300453.SZ 2024/4/17 3.31 21.34%0.47 28.61%8 000739.SZ 2024/4/18 31.98 3.65%2.39 2.42%9 000915.SZ 2024/4/18 5.72 1.85%1.62 4.99%10 301363.SZ 2024/4/18 2.82-23.34%0.56-44.38%11 600276.SH 2024/4/18 59.98 9.20%14.40 18.06%12 688050.SH 2024/4/18 3.10 63.55%0.99 31.70%13 688626.SH 2024/4/18 1.69 18.12%0.36 12.07%14 835892.BJ 2024/4/19 0.69-9.53%0.02-49.11%15 300181.SZ 2024/4/19 6.73 35.75%1.44 50.01%16 300357.SZ 2024/4/19 2.16 18.08%0.73 6.80%17 300396.SZ 2024/4/19 6.63 99.60%1.19 55.53%18 600594.SH 2024/4/19 5.73-16.26%-0.71-322.54%19 603309.SH 2024/4/19 3.09-14.49%0.47-53.10%20 603658.SH 2024/4/19 10.89 5.09%3.14 33.15%21 688358.SH 2024/4/19 1.41-14.87%0.45-13.17%22 002728.SZ 2024/4/20 1.65-45.88%0.09-91.47%23 600976.SH 2024/4/20 9.70-4.27%0.90 0.05%24 000661.SZ 2024/4/20 31.77 14.39%8.47-0.86%25 688276.SH 2024/4/20 2.70 50.64%0.60 228.87%26 600422.SH 2024/4/20 18.53-3.01%1.13 9.11%27 000999.SZ 2024/4/20 72.94 14.82%13.28 17.38%28 002817.SZ 2024/4/20 1.18-17.33%0.14-18.57%研报 识别风险，发现价值 请务必阅读末页的免责声明 11/28 T ab l e _ P ag eT e x t 跟踪分 析|医药 生物 29 600829.SH 2024/4/20 25.98-2.09%0.77 8.80%30 002262.SZ 2024/4/20 13.58 15.16%2.67 16.62%31 300314.SZ 2024/4/20 1.55-1.61%0.39-11.14%32 600566.SH 2024/4/20 24.03 0.60%7.26 19.83%33 600993.SH 2024/4/20 9.55 14.70%1.93 35.67%34 002653.SZ 2024/4/20 7.52 20.60%0.30 14.28%35 002898.SZ 2024/4/20 0.69-12.52%0.01-8.28%36 300003.SZ 2024/4/20 19.22-21.14%4.56-18.85%37 300436.SZ 2024/4/20 1.20 36.06%-0.17-72.15%38 300558.SZ 2024/4/20 7.36 38.40%0.90 390.39%39 301520.SZ 2024/4/20 0.90 25.14%0.23-5.41%40 600436.SH 2024/4/20 31.71 20.58%9.88 28.23%41 603079.SH 2024/4/20 1.85 9.19%0.01-238.64%42 603669.SH 2024/4/20 0.77 4.85%-0.20-10.67%43 603998.SH 2024/4/20 4.38 0.37%0.54 9.61%44 688266.SH 璟-U 2024/4/20 1.08 0.12%-0.43-33.51%45 688575.SH 2024/4/20 4.31-34.65%0.57-31.29%46 688799.SH 2024/4/20 3.73 4.38%0.44 0.28%wind 研报 识别风险，发现价值 请务必阅读末页的免责声明 12/28 T ab l e _ P ag eT e x t 跟踪分 析|医药 生物 biotech 2.47%300 2.26 0.9 pharma biotech A Pharma ST 7 A pharma 8 A ph ar ma Wind Wind H Pharma 9 H pharma 10 H ph arm a Wind Wind 11.4%8.5%6.8%6.8%4.0%0%2%4%6%8%10%12%-7.7%-7.8%-13.1%-13.3%-14.1%-16%-14%-12%-10%-8%-6%-4%-2%0%ST2.7%-0.2%-0.5%-0.6%-1.4%-2%-1%0%1%2%3%-4.5%-4.8%-5.1%-5.4%-12.7%-14%-12%-10%-8%-6%-4%-2%0%研报 识别风险，发现价值 请务必阅读末页的免责声明 13/28 T ab l e _ P ag eT e x t 跟踪分 析|医药 生物 A biotech-U-U-U-U-U 璟-U-U 11 A biotech 12 A biot e ch Wind Wind H biotech-B-B-B-B-B-B-B-B-B-B 13 H biotech 14 H biot e ch Wind Wind 15.5%4.1%2.7%-2.2%-2.3%-4%-2%0%2%4%6%8%10%12%14%16%18%-U-U-8.5%-8.7%-10.2%-10.5%-11.5%-14%-12%-10%-8%-6%-4%-2%0%首 药 控股-U 泽 璟 制药-U 益 方 生物-U 盟 科 药业-U 迪 哲 医药-U32.3%11.8%11.1%3.6%1.7%0%5%10%15%20%25%30%35%-10.3%-10.8%-10.9%-16.4%-34.7%-40%-35%-30%-25%-20%-15%-10%-5%0%-B-B-B-B-B 研报 识别风险，发现价值 请务必阅读末页的免责声明 14/28 T ab l e _ P ag eT e x t 跟踪分 析|医药 生物 15 16 Wind Wind 1.IND NDA 30 IND 27 3 1.1 2 NDA IND 1 CXZS2400012 1.1 2024/4/20 2 CXSL2400254 KY-0118 1 2024/4/20 3 CXSL2400253 BGB-B2033 1 2024/4/20 4 CXSL2400252 EX101 1 2024/4/20 5 CXHL2400406 WSD0922-FU 1 2024/4/20 6 CXSL2400250 VPD/FC01008 1 2024/4/19 7 CXHL2400403 FH-2001 1 2024/4/19 8 CXHL2400401 HRS-1358 1 2024/4/19 9 CXSL2400249 1 2024/4/19 10 CXSL2400246 WST03 1 2024/4/18 11 CXHL2400399 YD0293 1 2024/4/18 7.8%5.4%5.1%4.7%4.6%0%1%2%3%4%5%6%7%8%9%-6.6%-6.8%-7.8%-9.9%-13.0%-14%-12%-10%-8%-6%-4%-2%0%研报 识别风险，发现价值 请务必阅读末页的免责声明 15/28 T ab l e _ P ag eT e x t 跟踪分 析|医药 生物 12 CXHL2400397 HRS-9813 1 2024/4/18 13 CXHL2400395 STC008 1 2024/4/18 14 CXSL2400244 mRNA 1.2 2024/4/17 15 CXSL2400243 PD-1 1 2024/4/17 16 CXSL2400242 CD30 T 1 2024/4/17 17 CXHL2400394 SYHA1813 1 2024/4/17 18 CXHL2400389 HJ787 1 2024/4/17 19 CXSL2400239 FL115 1 2024/4/17 20 CXSL2400238 TQB2928 1 2024/4/17 21 CXSL2400237 BL-M17D1 1 2024/4/17 22 CXZL2400020 1.1 2024/4/16 23 CXSL2400236 BR105 1 2024/4/16 24 CXSL2400235 VPD/FC01002 1 2024/4/16 25 CXSL2400233 mRNA 1.2 2024/4/16 26 CXSL2400232 HER3 1 2024/4/16 27 CXHL2400376 VIC-1911 1 2024/4/16 28 CXHL2400375 GP681 1 2024/4/16 29 JXSL2400077 Axatilimab 1 Incyte CorporationIncyte Biosciences Shanghai Co.,Ltd.2024/4/19 30 JXSL2400076 Amlitelimab 1 Scleroderma Research Foundation,Inc.Beijing Medpace Ltd.2024/4/17 31 JXHL2400092 BAY 3283142 1 Bayer AGBayer Healthcare Company Ltd.2024/4/16 NMPA 研报 识别风险，发现价值 请务必阅读末页的免责声明 16/28 T ab l e _ P ag eT e x t 跟踪分 析|医药 生物 2.3 300401.SZ“”2,494,400 20.79%300401.SZ 2023 10 0.71 541,702,388 38,460,870 300702.SZ 00867.HK 002099.SZ BJV GMP 833230.BJ“”“”1,800 3,500 605507.SH 2024 4 17 2024 4 16 5,455,079 0.98%03320.HK 30 24 002102.SZ 43,000“”002102.SZ 5,000 130 002365.SZ 2023 12 31 294,682,500 10 1()29,468,250.00 300765.SZ 1,488,200 1,169,253,954 10 3.2 374,161,265.28 002693.SZ 600062.SH 688513.SH 300016.SZ 80%80%20,200 300630.SZ 688506.SH-U BL-B01D1 EGFR HER3-ADC 002653.SZ HSK16149 600196.SH HLX53 TIGIT Fc HCC 研报 识别风险，发现价值 请务必阅读末页的免责声明 17/28 T ab l e _ P ag eT e x t 跟踪分 析|医药 生物 600196.SH 600380.SH TG-1000 300199.SZ 600276.SH 10 2 6,379,002,274 7,646,166 1,274,271,221.60 000963.SZ 1,754,327,548 10 5.8 1,017,509,977.84 600196.SH 06600.HK 2024 4 17 330,800 300558.SZ EYP-1901 01177.HK 1 ROVADICITINIB TQ05105 300110.SZ“”002940.SZ“H-Z-01”002653.SZ 1,114,117,970 10 2.00 222,823,594.00 300558.SZ 418,485,885 10 1.70 71,142,600.45 002898.SZ 176,000,000 10 0.20 3,520,000.00 2023 36.92%02696.HK HLX53 TIGIT Fc 02257.HK-B isSCC siRNA STP705 wind 研报 识别风险，发现价值 请务必阅读末页的免责声明 18/28 T ab l e _ P ag eT e x t 跟踪分 析|医药 生物 1.89%300 1.68 0.32 17 18 Wind Wind 4 300601.SZ 20 06660.HK 10,420,212.00 H 000403.SZ 300294.SZ 504,248,738 10 3.000000 151,274,621.40 688278.SH wind 3.4%3.4%1.8%1.4%0.4%0%1%1%2%2%3%3%4%4%-2.6%-3.0%-4.3%-5.7%-6.4%-7%-6%-5%-4%-3%-2%-1%0%研报 识别风险，发现价值 请务必阅读末页的免责声明 19/28 T ab l e _ P ag eT e x t 跟踪分 析|医药 生物 2.20%300 1.99 0.64 A 19 A 20 A Wind Wind H-B-B-B-B-B 21 H 22 H Wind Wind 18.2%12.7%12.0%7.7%5.9%0%2%4%6%8%10%12%14%16%18%20%-9.8%-10.5%-10.9%-11.5%-12.0%-14%-12%-10%-8%-6%-4%-2%0%14.9%4.5%2.5%2.4%2.0%0%2%4%6%8%10%12%14%16%-8.1%-9.4%-12.0%-16.0%-19.6%-25%-20%-15%-10%-5%0%-B-B 研报 识别风险，发现价值 请务必阅读末页的免责声明 20/28 T ab l e _ P ag eT